Breaking News

Novasep Names Synthesis BU President

By Kristin Brooks | January 16, 2014

Van Nieuwenhove brings extensive experience

Thierry Van Nieuwenhove has been appointed president of Novasep’s Synthesis Business Unit in Pompey, France. Mr. Van Nieuwenhove joins the company from Ajinomoto-Omnichem, a European synthetic molecules custom manufacturing organization, where he held positions as director, and general manager and member of the board. His experience includes driving business unit growth, leading global teams including sales and business development, R&D, supply chain and purchasing, as well as mergers and acquisitions.
 
“We are thrilled to welcome Thierry to Novasep as president of the Synthesis Business Unit,” said Michel Spagnol, chief executive officer of Novasep. “His broad experience in driving multicultural custom synthesis businesses will complement our COMEX skills perfectly. Thierry possesses the dynamics to boost Novasep’s CMO business in all our key markets.”
 

blog comments powered by Disqus
  • 16th Annual $alary $urvey

    16th Annual $alary $urvey

    Tim Wright, Editor||June 3, 2015
    Welcome to Contract Pharma’s Sixteenth Annual Salary Survey! This year’s results are derived from more than 500 respondents f

  • Newsmakers: PCI

    Newsmakers: PCI

    Tim Wright, Editor||June 2, 2015
    PCI execs talk about the recent opening of the company’s new North American clinical facility, as well as other trends in the market

  • How Sterilization of Primary Packaging Influences the Results of E&L Studies

    How Sterilization of Primary Packaging Influences the Results of E&L Studies

    Thorsten Sogding, Daniel Canton, Daniel Haines, Uwe Rothhaar, SCHOTT Pharma Services ||June 2, 2015
    As the demands that are being placed on the quality and stability of medications continue to increase, the interactions that take place between the primary packaging container and filled drug product are becoming increasingly important